Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device coverage policy

This article was originally published in The Gray Sheet

Executive Summary

General Accounting Office plans to release a report on coverage decisions for new procedures and devices in June, in time to influence congressional debate over Medicare reform legislation, Health Care-Program Administration & Integrity Issues Director Leslie Aronowitz tells HHS secretary's regulatory reform committee in Washington, D.C. Jan. 7. Initiated by GAO, the study will examine the national coverage process, local carrier decisions, and the "hundreds and hundreds of [CPT and HCPCS] codes that get assimilated into the payment system without any formal [coverage] process. We need to understand the extent to which this happens and the rationale that underlies the different pathways," she says...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015974

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel